Madrigal Pharmaceuticals, Inc. MDGL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s common stock?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported common stock of 200M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s common stock has grown at a 900.0% compound annual growth rate (CAGR), from 2K to 200M.
- What does common stock mean?
- The total par value of all common shares issued by the company.
- How do you interpret common stock?
- An increase indicates new share issuance, while a decrease suggests share buybacks or cancellations.
- How does common stock compare across companies?
- Standard across all public companies; usually a nominal amount relative to total equity.